Search by
Industry
Department

Medical Device Vigilance Planning under the Revised MDD

This audio conference sponsored by:


SQA website



Audio conference highlights


Manufacturers placing medical devices on the market must have a vigilance system in place to collect and evaluate reported incidents. To prevent the recurrence of such incidents it may be necessary to take corrective actions. At a higher level, the vigilance system forms an integral part of a post-market surveillance system (PMS). In the EU the medical device directives (MDDs) establish the principal mechanisms for providing feedback about medical devices. Provisions regarding vigilance and PMS are outlined in various annexes to the MDDs: Active Implantable Medical Devices Directive (AIMDD); Medical Devices Directive (MDD), as amended; and In Vitro Device Directive (IVDD), as amended.


This audio conference provides information on various aspects of the legislation and how it is affecting medical device manufacturers, including real-life experiences to date and lessons learned from those who have been through the process.


This audio conference covers:


  • Main features of a post-marketing surveillance system
  • Main features of a vigilance system
  • Effect of the MDD revisions on vigilance obligations
  • The interaction of the PMS system with EN ISO 13485 and EN ISO 14971


About the speaker:


Salma Michor, PhD, is CEO and Principal Consultant with Michor Consulting EU. Michor acts as an independent expert for the European Commission evaluating industrial and other research projects. She teaches regulatory affairs and clinical strategies at two MBA courses offered by the University of Krems, in Austria. Before starting her own consulting business Michor worked in regulatory with Chiesi-Torrex and Wyeth Whitehall export. In her last assignment as director of supporting operations at Croma Pharma GmbH she supervised diverse departments including regulatory affairs and compliance, change control, pharmaceutical editing and pharmacovigilance, vigilance and medical writing.


Michor received her PhD in Thermal Process Engineering, and her MSc in Food & Biotechnology from the University of Applied life Sciences in Vienna, Austria. She holds the EU RAC and an MBA from the Open University in UK. She is a chartered manager and a fellow of the chartered manager institute. Michor is a member of RAPS Board of Editors for Regulatory Focus magazine and serves on the RAPS European Committee.


Who should attend?


  • Regulatory Affairs
  • Quality Assurance Mangers
  • Vigilance
  • Safety Officer/Managers
  • General Management


Speaker & Time

Salma Michor, Michor Consulting EU
Medical Device Vigilance Planning under the Revised MDD
Title: CEO and Principal Consultant
Duration: 60 minutes
Discount: Buy 2 items, get 25% off your order using coupon code FX25%OFF
Event Type: Previously recorded on 2010-04-13
Item #: ac20100413
13 Apr 2010 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 3 reviews)

Showing 3 Reviews:

by J.C.
Quality/Regulatory Affairs Leader
Overall, the contect is substantial and useful. But the speaker is talking a bit too fast to follow. Understand the time constraints and the amount of material to cover, hence it is important to take that into consideration when planning a webinar like this.
by H.W.
Supplier Engineer
Four of us missed the first 10 slides of the audio conference because of the following: I called in a few minutes before the conference and was asked for my confirmation number, which I did not have with me. I offered the conference ID (PIN), but that was not acceptable, so I disconnected the line, returned to my PC in another part of the building, and printed out the confirmation e-mail. I returned to the conference room and called in again and then waited until the phone was answered. This time I provided the confirmation number, which was of no value to the person answering the phone. I provided the time of the conference and the conference ID (PIN), and was connected to the conference. At that point the conference speaker was already on Slide 11. Please makes changes to your login procedure. I suggest one or more of the following: 1) Add the confirmation number requirement to the DIAL-IN INSTRUCTIONS e-mailed prior to the audio conference. 2) Instruct the person who answers the telephone to recognize
by A.E.
Surgical Services Pharmacist
Audio conference was well organised and technical/sound quality was excellent. Talk was well delivered and speaker met the objectives for this talk. Overall, very happy with the experience.
Rate this item
 
Recently Viewed
More about Creating and Sustaining Successful Pharma & Biotech Alliance Teams


Untapped Clinical Development Opportunity in Latin America
Dr. Alberto Grignolo, Diego Glancszpigel & Graciela Racaro, PAREXEL
More about Untapped Clinical Development Opportunity in Latin America


Risk Management Strategies: US vs. EU
Dr. Annette Stemhagen, United BioSource Corporation & Dr. Stefan Blesse, Granzer Regulatory Consulting
More about Risk Management Strategies: US vs. EU


More about Indications: The Next Battleground in FDA Advertising Enforcement


More about EU Medical Device eLabeling, Compliance & Software Requirements

© Copyright 2010
ForeignExchange Translations.
All rights reserved.

Home  |   FAQ  |   Blog  |   Translation Services  |   Search  |   Privacy Policy  |   Terms of Use  |   Contact Us